
Opinion|Videos|April 1, 2024
Key Takeaways Regarding Operationalizing Bispecific Antibodies for MM
Panelists summarize key takeaways on using bispecific antibodies for multiple myeloma treatment.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FAQ: Guidance for Pharmacists, SSRIs Under Scrutiny and Political Debate
2
Atezolizumab Receives FDA Approvals for MIBC With Molecular Residual Disease
3
How Clinical Pharmacists Optimize Obstructive Hypertrophic Cardiomyopathy Care
4
How Advanced Technology Is Reshaping Medication Safety and Pharmacy Practice
5





































































































































